76 related articles for article (PubMed ID: 21747022)
1. Increased risk of renal cell carcinoma after hysterectomy: possible causes and implications.
Goldstein MR; Mascitelli L
Arch Intern Med; 2011 Jul; 171(13):1214-5; author reply 1215-6. PubMed ID: 21747022
[No Abstract] [Full Text] [Related]
2. Increased risk of renal cell carcinoma subsequent to hysterectomy.
Gago-Dominguez M; Castelao JE; Yuan JM; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):999-1003. PubMed ID: 10566555
[TBL] [Abstract][Full Text] [Related]
3. Risk of renal cell carcinoma after hysterectomy.
Altman D; Yin L; Johansson A; Lundholm C; Grönberg H
Arch Intern Med; 2010 Dec; 170(22):2011-6. PubMed ID: 21149759
[TBL] [Abstract][Full Text] [Related]
4. [Angiogenesis: the renal cancer model].
Méjean A; Lebret T
Prog Urol; 2008 Nov; 18 Suppl 7():S309-14. PubMed ID: 19070808
[TBL] [Abstract][Full Text] [Related]
5. Risk of renal cell carcinoma after hysterectomy: is it all obesity?
Dimmitt SB
Arch Intern Med; 2011 Jul; 171(13):1215; author reply 1215-6. PubMed ID: 21747023
[No Abstract] [Full Text] [Related]
6. Does growth hormone treatment affect the risk of post-transplant renal cancer?
Mehls O; Wilton P; Lilien M; Berg U; Broyer M; Rizzoni G; Waldherr R; Opelz G
Pediatr Nephrol; 2002 Dec; 17(12):984-9. PubMed ID: 12520324
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of neovascularization and vascular endothelial growth factor in human renal cell carcinoma].
Sato K; Kato T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):389-94. PubMed ID: 9063473
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between expression of matrix metalloproteinase-9 (MMP-9) and angiogenesis in renal cell carcinoma].
Zhang Y; Wu XH; Cao GH; Li S
Ai Zheng; 2004 Mar; 23(3):326-9. PubMed ID: 15025968
[TBL] [Abstract][Full Text] [Related]
9. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
[TBL] [Abstract][Full Text] [Related]
10. Interview with professor Per-Anders Abrahamson: angiogenesis and renal cell carcinoma.
Abrahamson PA
Eur Urol; 2006 Sep; 50(3):609-11. PubMed ID: 16824676
[No Abstract] [Full Text] [Related]
11. Re: "Population attributable risk of renal cell cancer in Minnesota".
Tavani A; Negri E; La Vecchia C
Am J Epidemiol; 1999 Jul; 150(2):222. PubMed ID: 10412972
[No Abstract] [Full Text] [Related]
12. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
[TBL] [Abstract][Full Text] [Related]
13. Recipient origin of vasculature in renal cell carcinoma in a kidney allograft.
Hill PA
Pathology; 2010; 42(5):479-80. PubMed ID: 20632827
[No Abstract] [Full Text] [Related]
14. Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma.
Fukata S; Inoue K; Kamada M; Kawada C; Furihata M; Ohtsuki Y; Shuin T
Cancer; 2005 Mar; 103(5):931-42. PubMed ID: 15685621
[TBL] [Abstract][Full Text] [Related]
15. [Renal cell carcinoma and prognostic factors].
Edeline J; Rioux-Leclercq N
Ann Pathol; 2008 Oct; 28(5):374-80. PubMed ID: 19068392
[TBL] [Abstract][Full Text] [Related]
16. Family history and risk of renal cell carcinoma.
Gago-Dominguez M; Yuan JM; Castelao JE; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1001-4. PubMed ID: 11535554
[TBL] [Abstract][Full Text] [Related]
17. The significance of angiogenesis and tumoral proliferation in renal cell carcinoma.
Puşcaşiu D; Tatu C; Tatu RF; Potencz E; Popescu R; Muntean I; Verdeş D
Rom J Morphol Embryol; 2011; 52(1 Suppl):369-72. PubMed ID: 21424076
[TBL] [Abstract][Full Text] [Related]
18. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
Klatte T; Patard JJ; Wunderlich H; Goel RH; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
J Urol; 2007 Jun; 177(6):2081-6; discussion 2086-7. PubMed ID: 17509291
[TBL] [Abstract][Full Text] [Related]
19. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
[TBL] [Abstract][Full Text] [Related]
20. Association between local atherosclerosis and renal cell carcinomas.
Hager M; Mikuz G; Kolbitsch C; Moser PL
Nutr Cancer; 2008; 60(3):364-7. PubMed ID: 18444170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
